Susan Tousi - World Medical Innovation Forum
WMIF Main Site
Susan Tousi
This speaker appears at this event:

Susan Tousi

SVP, Product Development,, Illumina, Inc.

Susan Tousi is Senior Vice President of Product Development at Illumina, Inc., (NASDAQ: ILMN), a company on a mission to improve human health by unlocking the power of the genome by delivering market and technology leading DNA sequencers. Illumina is a global company headquartered in San Diego, California. Susan is responsible for Illumina’s global engineering, consumables, sequencing applications, software and informatics development efforts, ensuring Illumina’s scientists and engineers continue the culture of innovation and product excellence that has been a hallmark of Illumina.

Under her leadership, Illumina has launched six years of industry leading sequencing platforms, and achieved the most innovative and expansive product portfolio in the company’s history, including the NovaSeq Series, a new and scalable sequencing architecture expected one day to enable a $100 genome; this platform redefines high throughput sequencing with unrivaled throughput, ease of use, low per sample costs, and unmatched flexibility.
With more than 25-years of R&D and business leadership at Fortune 100 technology companies and within the life sciences industry, Susan continuously relies upon her deep passion for people, teams, culture, inclusion and innovation to lead the creation and commercialization of innovative products. Susan has been a vital asset to Illumina as she has helped navigate the organization through significant scaling and growth – the company has more than doubled in revenues since she joined the team in 2012. Formerly, Susan was as a Corporate Vice President and General Manager for Eastman Kodak’s Consumer Inkjet Systems organization. Prior to joining Kodak, Susan was an R&D program manager for Phogenix Imaging LLC, a joint venture start-up of Hewlett-Packard and Kodak. She previously spent 10 years with Hewlett-Packard in technical and management roles.
In 2017, Illumina was recognized by MIT Technology Review’s 50 Smartest Companies (for the 5th straight year), Forbes’ 2017 America’s Best Mid-Size Employers, BioSpace’s 2017 Life Sciences Ideal Employers, and Computerworld’s Best Places to Work in IT.

Susan holds an M.B.A. degree from UCLA and a B.S. in Engineering Science and Mechanics from Pennsylvania State University. Along with many academic honors, she has received numerous awards in both business and technology, most recently being named a finalist for 2017 Businesswoman of the Year by San Diego Business Journal.
Susan is a lover of the arts and serves as a trustee at the world renowned La Jolla Playhouse; she is a proud mom, and an avid art history student who believes and strives to live by the simple leadership philosophy: “transformative products come from bringing out the best in our people.” Susan resides in the San Diego area with her husband, Randall Camp, and is the proud mother of three boys; Brandon Camp (19), Spencer Camp (17), and Cameron Camp (9).

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA